Valuation: DiaSorin S.p.A.

Market Cap 3.71B 4.24B 3.42B 3.19B 6.02B 401B 6.12B 41.06B 15.94B 198B 15.92B 15.56B 689B P/E 2026 *
20.3x
P/E 2027 * 17.8x
Enterprise Value 4.38B 5.01B 4.05B 3.77B 7.11B 473B 7.24B 48.52B 18.84B 234B 18.81B 18.39B 814B EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.25x
Free-Float
-
Yield 2026 *
1.87%
Yield 2027 * 1.95%
1 day-3.14%
1 week+5.12%
Current month+1.86%
1 month+1.22%
3 months+14.85%
6 months-1.25%
Current year-1.25%
1 week 64.56
Extreme 64.56
70.26
1 month 62.96
Extreme 62.96
75.3
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.14%+5.12%-25.42%-28.97% 4.23B
-2.44%+14.73%+188.44%+319.29% 20.39B
-1.65%+3.15%-41.48%-28.53% 9.41B
+1.22%+4.58%+35.46%+32.14% 7.13B
-3.11%+0.85%-33.57% - 5.18B
-2.33%-1.18%-24.99%-28.43% 4.97B
+1.52%+18.70%+226.68%-32.25% 4.72B
+5.76%-3.02%+96.33%+102.81% 4.11B
-2.94%-3.88%-22.30%-43.68% 2.51B
-1.24%+0.29%-37.32%-58.09% 1.24B
Average -0.76%+5.37%+36.18%+26.03% 6.39B
Weighted average by Cap. -1.17%+9.15%+72.96%+107.21%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.06B 1.99B 133B 2.03B 13.58B 5.27B 65.4B 5.27B 5.15B 228B 1.31B 1.49B 1.21B 1.13B 2.12B 141B 2.16B 14.47B 5.62B 69.65B 5.61B 5.48B 243B
Net income 182M 207M 168M 156M 295M 19.61B 300M 2.01B 780M 9.68B 779M 762M 33.72B 205M 235M 190M 177M 333M 22.2B 339M 2.28B 883M 10.95B 882M 862M 38.16B
Net Debt 674M 770M 622M 580M 1.09B 72.81B 1.11B 7.46B 2.9B 35.93B 2.89B 2.83B 125B 543M 620M 501M 468M 881M 58.66B 897M 6.01B 2.33B 28.95B 2.33B 2.28B 101B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-06-30 67.76 -3.14% 238,260
26-06-29 €69.96 +2.37% 331,777
26-06-26 €68.34 +2.92% 208,577
26-06-25 €66.40 -0.12% 239,419
26-06-24 €66.48 +3.13% 223,750
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
69.96EUR
Average target price
70.52EUR
Spread / Average Target
+0.80%

Quarterly revenue - Rate of surprise